[Metameric macular and papular skin mastocytosis]. En savoir plus sur [Metameric macular and papular skin mastocytosis].
Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing. En savoir plus sur Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.
Actionable Genes, Core Databases, and Locus-Specific Databases. En savoir plus sur Actionable Genes, Core Databases, and Locus-Specific Databases.
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant. En savoir plus sur Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors. En savoir plus sur The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations. En savoir plus sur Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome. En savoir plus sur Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome.
Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. En savoir plus sur Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue.
Characterisation of heterozygous <i>PMS2</i> variants in French patients with Lynch syndrome. En savoir plus sur Characterisation of heterozygous PMS2 variants in French patients with Lynch syndrome.
Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile. En savoir plus sur Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile.